119 related articles for article (PubMed ID: 38881743)
1. The Future Frontier of Liver Transplantation Exploring Young Donor Allocation Strategies for HCC Recipients.
Akabane M; Esquivel CO; Kim WR; Sasaki K
Transplant Direct; 2024 Jul; 10(7):e1657. PubMed ID: 38881743
[TBL] [Abstract][Full Text] [Related]
2. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.
Chen J; Yang Z; Gao F; Zhou Z; Chen J; Lu D; Wang K; Sui M; Wang Z; Guo W; Lyu G; Qi H; Cai J; Yang J; Zheng S; Xu X
Cancer Biol Med; 2024 Feb; 21(4):347-62. PubMed ID: 38425217
[TBL] [Abstract][Full Text] [Related]
3. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Silverstein J; Roll G; Dodge JL; Grab JD; Yao FY; Mehta N
Liver Transpl; 2020 Sep; 26(9):1100-1111. PubMed ID: 32531867
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience.
Wehrle CJ; Raj R; Maspero M; Satish S; Eghtesad B; Pita A; Kim J; Khalil M; Calderon E; Orabi D; Zervos B; Modaresi Esfeh J; Whitsett Linganna M; Diago-Uso T; Fujiki M; Quintini C; Kwon CD; Miller C; Pinna A; Aucejo F; Hashimoto K; Schlegel A
Int J Surg; 2024 May; 110(5):2818-2831. PubMed ID: 38241354
[TBL] [Abstract][Full Text] [Related]
5. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
[TBL] [Abstract][Full Text] [Related]
6. Expanding Selection Criteria in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: Long-term Follow-up of a National Registry and 2 Transplant Centers.
Wehrle CJ; Kusakabe J; Akabane M; Maspero M; Zervos B; Modaresi Esfeh J; Whitsett Linganna M; Imaoka Y; Khalil M; Pita A; Kim J; Diago-Uso T; Fujiki M; Eghtesad B; Quintini C; Kwon CD; Pinna A; Aucejo F; Miller C; Mazzaferro V; Schlegel A; Sasaki K; Hashimoto K
Transplantation; 2024 Jun; ():. PubMed ID: 38831488
[TBL] [Abstract][Full Text] [Related]
7. AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision tool.
Piñero F; Costentin C; Degroote H; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas A; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Dibenedetto F; Duque SH; Salame E; Cillo U; Marciano S; Vanlemmens C; Fagiuoli S; Carrilho F; Cherqui D; Burra P; Van Vlierberghe H; Lai Q; Silva M; Rubinstein F; Duvoux C; ; ; ; ;
JHEP Rep; 2023 Feb; 5(2):100644. PubMed ID: 36691474
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
[TBL] [Abstract][Full Text] [Related]
9. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
Sharma P; Welch K; Hussain H; Pelletier SJ; Fontana RJ; Marrero J; Merion RM
Dig Dis Sci; 2012 Mar; 57(3):806-12. PubMed ID: 21953139
[TBL] [Abstract][Full Text] [Related]
12. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
Vagefi PA; Dodge JL; Yao FY; Roberts JP
Liver Transpl; 2015 Feb; 21(2):187-94. PubMed ID: 25371243
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.
Krishnamoorthi R; Manickam P; Cappell MS
Minerva Gastroenterol Dietol; 2014 Jun; 60(2):113-8. PubMed ID: 24780945
[TBL] [Abstract][Full Text] [Related]
14. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.
Mohamed IB; Ismail MS; El Sabagh A; Afifi Abdelwahab AM; Polychronopoulou E; Kuo YF; Hassan M; Goss JA; Kanwal F; Jalal PK
Cancer Med; 2023 Jul; 12(14):15011-15025. PubMed ID: 37326440
[TBL] [Abstract][Full Text] [Related]
15. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
Salgia RJ; Goodrich NP; Marrero JA; Volk ML
Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
[TBL] [Abstract][Full Text] [Related]
16. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
Cucchetti A; Serenari M; Sposito C; Di Sandro S; Mosconi C; Vicentin I; Garanzini E; Mazzaferro V; De Carlis L; Golfieri R; Spreafico C; Vanzulli A; Buscemi V; Ravaioli M; Ercolani G; Pinna AD; Cescon M
J Hepatol; 2020 Aug; 73(2):342-348. PubMed ID: 32201284
[TBL] [Abstract][Full Text] [Related]
17. Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.
Lasagni S; Leonardi F; Pivetti A; Di Marco L; Ravaioli F; Serenari M; Gitto S; Critelli RM; Milosa F; Romanzi A; Mancarella S; Dituri F; Riefolo M; Catellani B; Magistri P; Romagnoli D; Celsa C; Enea M; de Maria N; Schepis F; Colecchia A; Cammà C; Cescon M; d'Errico A; di Benedetto F; Giannelli G; Martinez-Chantar ML; Villa E
Front Oncol; 2022; 12():960808. PubMed ID: 36158651
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
[TBL] [Abstract][Full Text] [Related]
19. Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
Sehjal J; Sharples LD; Keogh RH; Walker K; Prachalias A; Heaton N; Ivanics T; van der Meulen J; Wallace D
Transplantation; 2022 Nov; 106(11):e464-e475. PubMed ID: 36017919
[TBL] [Abstract][Full Text] [Related]
20. Utilization of elderly donors in liver transplantation for patients with hepatocellular carcinoma: A national retrospective cohort study of China.
Hu L; Zhao Z; Mu F; Dong S; Zhang C; Shi J; Tian M; Guo K; Zhang X; Yu L; Lv Y; Wang B
Int J Surg; 2022 Sep; 105():106839. PubMed ID: 35987333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
